GGrantIndex
Sort

51,593 grants matching hepatitis

HDL metabolism: Influence of extracellular lipases

$400,000
Daniel James Rader · University Of Pennsylvania · R37 · FY2014 · HL

TTC39B in Metabolism

$400,000
Alan Richard Tall · Columbia University Health Sciences · R01 · FY2016 · HL

Hepatic PLTP as a target for lowering LDL-c

$400,000
Weijun Jin · Suny Downstate Medical Center · R56 · FY2014 · HL

RADx Innovation Funnel for Hepatitis B Diagnostics – Commercialization Center

$400,000
Mark Marino · Venturewell · N02 · FY2024 · HL

Cellular and transcriptional control of exhausted CD8 T cells lineage dynamics

$400,000
E. John Wherry · University Of Pennsylvania · R01 · FY2017 · AI

Novel mechanism underlying fibrinogen biogenesis in the endoplasmic reticulum

$399,999
Shengyi Sun · Wayne State University · R01 · FY2022 · DK

Community-based Hep B Intervention for Hmong Adults

$399,991
Moon S Chen · University Of California At Davis · P01 · FY2008 · CA

Smartphone Enabled Point-of-Care Detection of Serum Markers of Liver Cancer

$399,986
Ashutosh Chilkoti · Duke University · UG3 · FY2017 · CA

IFNGR Down Regulation as a Host Target for Therapy of Infectious Diseases

$399,947
Laurel L Lenz · University Of Colorado Denver · R33 · FY2014 · AI

Environmental Obesogens and Weight Change in the POUNDS LOST Trial

$399,934
Qi Sun · Harvard School Of Public Health · R01 · FY2014 · ES

Interstitial Chemophototherapy with Light-Activated Nanoparticulate Doxorubicin

$399,917
Gal Shafirstein · Pop Biotechnologies, Inc · R41 · FY2020 · CA

Children's Exposure to Flame Retardants: Effects on Thyroid Hormone Regulation

$399,914
Heather M Stapleton · Duke University · R01 · FY2010 · ES

Field-deployable platform for prognostic hepatic cancer screening in low-resource settings

$399,914
Marc D Porter · University Of Utah · UG3 · FY2017 · CA

HCV-Specific Cellular Immunity in Acute Hepatitis C

$399,908
Research Inst Nationwide Children'S Hosp · U19 · FY2005 · AI

Scavenger Receptor BI in Cellular Cholesterol Metabolism

$399,896
Erwin London · State University New York Stony Brook · R01 · FY2008 · HL

3/4-The INTEGRATE Study: Evaluating INTEGRATEd Care to Improve Biopsychosocial Outcomes of Early Liver Transplantation for Alcohol-Associated Liver Disease

$399,892
David Seth Goldberg · University Of Miami School Of Medicine · R01 · FY2025 · AA

Mechanism and Fidelity of DNA Replication

$399,887
University Of Texas Austin · R01 · FY2004 · GM

Optimizing Therapeutic Revascularization by Endothelial Cell Transplantation

$399,840
W Mark Saltzman · Yale University · R01 · FY2015 · HL

Nucleotide inhibitors as precision medicine in breast cancer

$399,757
Richard T Pomerantz · Recombination Therapeutics, Llc · R41 · FY2020 · CA

Developmental regulation of HBV biosynthesis by FoxA and DNA methylation

$399,750
Alan McLachlan · University Of Illinois At Chicago · R01 · FY2020 · AI

Chemokines in Autoimmune Hepatitis

$399,750
James D. Gorham · Dartmouth College · R01 · FY2009 · AI

Highly Attenuated Vesiculovirus-based Vectors as HBV Therapeutic Vaccines

$399,750
Michael D Robek · Albany Medical College · R01 · FY2018 · AI

Developmental regulation of HBV biosynthesis by FoxA and DNA methylation

$399,750
Alan McLachlan · University Of Illinois At Chicago · R01 · FY2019 · AI

Role of APOBEC3 in in vivo Restriction of Retrovirus Infection

$399,750
Susan R Ross · University Of Illinois At Chicago · R01 · FY2019 · AI

Highly Attenuated Vesiculovirus-based Vectors as HBV Therapeutic Vaccines

$399,750
Michael D Robek · Albany Medical College · R01 · FY2017 · AI